Essemedical is Omixon’s New Distributor

28/08/2020

Omixon welcomes Essemedical s.r.l. as our New Distributor in Italy Omixon is pleased to announce the signature of a Distribution Agreement with Essemedical s.r.l. (Dia4it s.r.l.), based in Vedano al Lambro (MB), Italy. The agreement is effective as of September 1st, 2020. Our cooperation will provide easier access to Omixon’s high-performance,...

Do We Outsmart the Virus or Does the Virus Outsmart Us?

26/05/2020

Written by Nina Lauterbach (FAS, Omixon) About 3,500 years ago, a scholar in Egypt started writing in the oldest medical text known in history. One of the diseases he described was something called Resh. The name is weird and unfamiliar, but the symptoms might ring a bell, a cough...

DNA Contamination Study Using Holotype HLA v2

03/07/2019

EFI 2019 User Group Meeting presentation by Dr. Dominique Masson (EFS HLA Laboratory, Grenoble), including analysis using Omixon’s HLA Twin software and featuring test results. The presentation can be downloaded from here…

Typing Buddies

26/07/2016

We all need a little reassurance sometimes… In the past few years Next Generation Sequencing has conquered immunology labs all around the world and is actively used in both research and diagnostics. But how was it possible to develop and validate these methods? How do we verify the accuracy...

Genotyping Engine Race – Measuring Performance (pt. 2)

22/06/2016

To read the first part of the article, click here… Much much much later… After all the sequencing and genotyping is finally done, it’s time to measure how good the results are. As usual, there is no single, perfect measure for calculating performance. Every measure has a different problem....